On September 24, 2022, Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. announced that the transaction is approved in 11th meeting of the 5th board of directors and the 9th meeting of the 5th board of supervisors. The Supplementary Agreement to the Subscription Agreement for Non-Public Issuance of Shares Effective with Conditions' was signed by the company and Lin Hongyuan.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.99 CNY | +2.83% | -3.15% | -40.42% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-40.42% | 418M | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B |
- Stock Market
- Equities
- 603168 Stock
- News Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.
- Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. announced that it expects to receive funding from Shanghai Yanghe Industrial Co., Ltd.